Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronjon Chakraverty

Blood

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Blood|January 29, 2026
Menin inhibitors: a 2-in-1 defense versus AML immune evasionRonjon Chakraverty
Blood|April 9, 2026
GVHD fails the acid testRonjon Chakraverty
Blood|March 1, 2007
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemiaRonjon Chakraverty, Megan Sykes
Blood|August 9, 2021
Graft-versus-host disease: a disorder of tissue regeneration and repairRonjon Chakraverty, Takanori Teshima
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
Blood|June 9, 2005
Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cellsLisa Freeman, Martin Hewison, Susan V Hughes, et al.
Blood|June 8, 2006
Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusionsRonjon Chakraverty, Hyeon-Seok Eom, Jessica Sachs, et al.
Blood|May 14, 2011
Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skinClare L Bennett, Farnaz Fallah-Arani, Thomas Conlan, et al.
Blood|November 8, 2003
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsFiona J Clark, Richard Gregg, Karen Piper, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Blood|January 29, 2026
Menin inhibitors: a 2-in-1 defense versus AML immune evasionRonjon Chakraverty
Blood|April 9, 2026
GVHD fails the acid testRonjon Chakraverty
Blood|March 1, 2007
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemiaRonjon Chakraverty, Megan Sykes
Blood|August 9, 2021
Graft-versus-host disease: a disorder of tissue regeneration and repairRonjon Chakraverty, Takanori Teshima
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
Blood|June 9, 2005
Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cellsLisa Freeman, Martin Hewison, Susan V Hughes, et al.
Blood|June 8, 2006
Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusionsRonjon Chakraverty, Hyeon-Seok Eom, Jessica Sachs, et al.
Blood|May 14, 2011
Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skinClare L Bennett, Farnaz Fallah-Arani, Thomas Conlan, et al.
Blood|November 8, 2003
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsFiona J Clark, Richard Gregg, Karen Piper, et al.
Blood|March 31, 2011
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccinationConstandina Pospori, Shao-An Xue, Angelika Holler, et al.
Pageof 2